Navigation Links
ITN's TrialShare wins National Academies Board on Research Data and Information challenge
Date:7/17/2014

Seattle, WA (July 16, 2014) The Immune Tolerance Network's (ITN) TrialShare Clinical Trials Research Portal has won the National Academy of Sciences Data and Information Challenge. The theme of this year's competition, launched and judged by the academy's Board on Research Data and Information (BDRI), was "Using Data for the Public Good."

The ITN's entry, entitled "ITN TrialShare: Enabling True Clinical Trial Transparency" describes the unique data sharing portal developed by the NIH-sponsored clinical research consortium. The system provides clinical trial investigators an unprecedented ability to share data with other researchers. Among its unique features are the ability to access raw de-identified participant level study data, review published analysis methods, and perform real-time interactive graphical analyses in collaboration with other researchers.

The BRDI Data and Information Challenge was created by the National Academy of Sciences as a means of increasing awareness of current issues surrounding the collection and use of scientific research data, including accessibility, integration, and reproducibility; as well as promoting new opportunities for novel analyses, allowing for maximum societal benefit from the available data.

With a number of high profile drug failures in the past decade, there is a growing movement within government, industry, and academia for greater transparency in the reporting of clinical trial results. Substantial progress has been made in reaching consensus on the need for change; however a number of technical and procedural challenges have limited the ability to implement effective solutions. ITN TrialShare has been created to specifically address many of these issues.

"Modern clinical trial data is highly complex, often including information related to genetic testing and other high throughput techniques that generate a lot of data," says Adam Asare, ITN Director of Bioinformatics. "What we've done is create a set of intuitive tools that allow researchers to share and analyze their data in multiple ways you can be an expert statistician or a novice, and find what you need."

Anyone with a valid email address can self-create a free ITN TrialShare account in minutes and start accessing hundreds of datasets for dozens of completed studies, data and analyses. ITN TrialShare currently has data and specimen bio-repository information associated with 35 trials and 3,200 participants available to the public in the therapeutic areas of transplant, allergy, autoimmunity, and type I diabetes. ITN makes the underlying data from all published and closed studies, regardless of outcome, available through TrialShare. ITN TrialShare was built and customized using the LabKey Server open source framework.


'/>"/>

Contact: Philip Bernstein
ITNCommunications@immunetolerance.org
240-235-6132
Immune Tolerance Network
Source:Eurekalert

Related biology news :

1. Researchers at LSTM crack the genetic secret of mosquito resistance to DDT and ITNs
2. National Xenopus resource at the MBL innovates new way to study proteins
3. Registration is now open for the HFES 2014 International Annual Meeting
4. Largest International Meeting for the Study of Reproductive Biology Attracts Researchers from 36 Countries in Grand Rapids, Michigan
5. International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019
6. National Electronic ID Programs Generate $54 Billion Between 2013 and 2018 with 3.5 Billion National eID Card Holders Worldwide
7. Marshall University to partner with international company in drug development venture
8. UC Riverside plant pathologist receives national recognition
9. Highlights for 2014 national meeting of worlds largest scientific society
10. The ICIST-KAIST International Conference 2014 from August 4-8, 2014 in Korea
11. International Tree Nut Council study results may help people with type 2 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... 2017   ivWatch LLC , a medical device company focused ... announced receipt of its ISO 13485 Certification, the global standard for ... for Standardization (ISO®). ... 400 Continuous Monitoring device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, ...
(Date:7/20/2017)... 2017 Delta (NYSE: DAL ) customers now can ... at Reagan Washington National Airport (DCA). ... Delta launches biometrics to board aircraft at Reagan ... Delta,s biometric boarding pass experience that ... now integrated into the boarding process to allow eligible Delta SkyMiles Members ...
(Date:6/30/2017)... , June 30, 2017 Today, ... developer and supplier of face and eye tracking ... Featured Product provider program. "Artificial ... innovative way to monitor a driver,s attentiveness levels ... from being able to detect fatigue and prevent ...
Breaking Biology News(10 mins):
(Date:8/16/2017)... England , Aug. 16, 2017  Kingfisher Talent, the ... and leadership development, and Virdis Group, global executive search specialists ... alliance that enables clients to leverage the expertise and reach ... our clients here in the Boston ... population of leadership talent throughout the US, Canada ...
(Date:8/15/2017)... ... ... Any expert in stem cell research or stem cell medicine knows well ... century. Despite their essential roles in human health and regenerative medicine, adult tissue ... for this purpose also tag other, more abundant, non-stem tissue cells ( See 2017 ...
(Date:8/14/2017)... ... August 14, 2017 , ... Every ... Key researchers in the antibody community have recently come together to address this ... in the laboratory. , The team at Thermo Fisher Scientific ...
(Date:8/11/2017)... ... 11, 2017 , ... Algenist continues to disrupt the skincare industry with today’s ... , Collagen is the key structural element skin needs to maintain its youthful ... , First to market with proprietary collagen water active ...
Breaking Biology Technology: